These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 21415878)

  • 21. The way forward in reproductive/developmental toxicity testing.
    Spielmann H
    Altern Lab Anim; 2009 Dec; 37(6):641-56. PubMed ID: 20105000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Using toxicological evidence from QSAR models in practice.
    Benfenati E; Pardoe S; Martin T; Gonella Diaza R; Lombardo A; Manganaro A; Gissi A
    ALTEX; 2013; 30(1):19-40. PubMed ID: 23338804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An alternative QSAR-based approach for predicting the bioconcentration factor for regulatory purposes.
    Gissi A; Gadaleta D; Floris M; Olla S; Carotti A; Novellino E; Benfenati E; Nicolotti O
    ALTEX; 2014; 31(1):23-36. PubMed ID: 24247988
    [TBL] [Abstract][Full Text] [Related]  

  • 24. An integrated decision-tree testing strategy for repeat dose toxicity with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Feb; 36(1):93-101. PubMed ID: 18333717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A critical evaluation of the 2011 ECHA reports on compliance with the REACH and CLP regulations and on the use of alternatives to testing on animals for compliance with the REACH regulation.
    Spielmann H; Sauer UG; Mekenyan O
    Altern Lab Anim; 2011 Oct; 39(5):481-93. PubMed ID: 22103941
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated decision-tree testing strategies for skin corrosion and irritation with respect to the requirements of the EU REACH legislation.
    Grindon C; Combes R; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():65-74. PubMed ID: 19025332
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eye Irritation Test (EIT) for Hazard Identification of Eye Irritating Chemicals using Reconstructed Human Cornea-like Epithelial (RhCE) Tissue Model.
    Kaluzhny Y; Kandárová H; d'Argembeau-Thornton L; Kearney P; Klausner M
    J Vis Exp; 2015 Aug; (102):e52979. PubMed ID: 26325674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?].
    Lilienblum W
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation of mechanistic categories and local models to facilitate the prediction of toxicity.
    Cronin MT; Enoch SJ; Hewitt M; Madden JC
    ALTEX; 2011; 28(1):45-9. PubMed ID: 21311849
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of an in vitro test battery for assessing chemical effects on bovine germ cells under the ReProTect umbrella.
    Lazzari G; Tessaro I; Crotti G; Galli C; Hoffmann S; Bremer S; Pellizzer C
    Toxicol Appl Pharmacol; 2008 Dec; 233(3):360-70. PubMed ID: 18835402
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ECVAM, ECETOC and the EU chemicals policy.
    Botham PA
    Altern Lab Anim; 2002 Dec; 30 Suppl 2():185-7. PubMed ID: 12513671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Developmental toxicity testing in the 21st century: the sword of Damocles shattered by embryonic stem cell assays?
    Seiler A; Oelgeschläger M; Liebsch M; Pirow R; Riebeling C; Tralau T; Luch A
    Arch Toxicol; 2011 Nov; 85(11):1361-72. PubMed ID: 22008952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The challenge of reproductive and developmental toxicology under REACH.
    Scialli AR
    Regul Toxicol Pharmacol; 2008 Jul; 51(2):244-50. PubMed ID: 18490093
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental neurotoxicity testing: recommendations for developing alternative methods for the screening and prioritization of chemicals.
    Crofton KM; Mundy WR; Lein PJ; Bal-Price A; Coecke S; Seiler AE; Knaut H; Buzanska L; Goldberg A
    ALTEX; 2011; 28(1):9-15. PubMed ID: 21311847
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A European perspective on alternatives to animal testing for environmental hazard identification and risk assessment.
    Scholz S; Sela E; Blaha L; Braunbeck T; Galay-Burgos M; García-Franco M; Guinea J; Klüver N; Schirmer K; Tanneberger K; Tobor-Kapłon M; Witters H; Belanger S; Benfenati E; Creton S; Cronin MT; Eggen RI; Embry M; Ekman D; Gourmelon A; Halder M; Hardy B; Hartung T; Hubesch B; Jungmann D; Lampi MA; Lee L; Léonard M; Küster E; Lillicrap A; Luckenbach T; Murk AJ; Navas JM; Peijnenburg W; Repetto G; Salinas E; Schüürmann G; Spielmann H; Tollefsen KE; Walter-Rohde S; Whale G; Wheeler JR; Winter MJ
    Regul Toxicol Pharmacol; 2013 Dec; 67(3):506-30. PubMed ID: 24161465
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated decision-tree testing strategies for acute systemic toxicity and toxicokinetics with respect to the requirements of the EU REACH legislation.
    Combes R; Grindon C; Cronin MT; Roberts DW; Garrod JF
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():91-109. PubMed ID: 19025334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An overview of current techniques for ocular toxicity testing.
    Wilson SL; Ahearne M; Hopkinson A
    Toxicology; 2015 Jan; 327():32-46. PubMed ID: 25445805
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of integrated testing strategies for REACH: motivation, background and introduction. Preface.
    Cronin MT; Garrod JF; Balls M
    Altern Lab Anim; 2008 Oct; 36 Suppl 1():i-iii. PubMed ID: 19130698
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.